<p>Molina Healthcare（纽约证券交易所代码：MOH - 获取免费报告）在周四早上发布了 2026 财年的收益指引更新。该公司提供的每股收益指引为 5.000-，而市场共识的每股收益预期为 5.180。该公司发布的收入指引为-。</p>
<p>获取 <strong>Molina Healthcare</strong> 的提醒：</p>
<h2>Molina Healthcare 股票表现</h2>
<ul>
<li>3 个下跌时值得购买的行业和 1 个应远离的行业</li>
</ul>
<p>周四，MOH 股票开盘价为 197.96 美元。该公司的 50 日移动平均线为 172.30 美元，200 日移动平均线为 163.88 美元。Molina Healthcare 的 12 个月低点为 121.06 美元，12 个月高点为 311.52 美元。该公司的市值为 103.1 亿美元，市盈率为 58.57，贝塔值为 0.80。该公司的速动比率为 1.63，流动比率为 1.63，债务股本比率为 0.97。</p>
<p>Molina Healthcare（纽约证券交易所代码：MOH - 获取免费报告）最近在 4 月 22 日（星期三）发布了季度财报。该公司报告季度每股收益为 2.35 美元，超出分析师共识预期的 1.57 美元，超出幅度为 0.78 美元。该季度的收入为 108 亿美元，而市场共识预期为 109.1 亿美元。Molina Healthcare 的净利润率为 0.42%，股本回报率为 8.76%。Molina Healthcare 的季度收入同比下降了 3.1%。去年同期，该公司每股收益为 6.08 美元。Molina Healthcare 已将其 2026 财年的指引设定为 5.000-每股收益。整体来看，股票分析师预计 Molina Healthcare 在当前财年将发布 5.23 美元的每股收益。</p>
<h2>分析师评级变动</h2>
<ul>
<li>Centene 股票为何下跌 40%——现在是否值得购买</li>
</ul>
<p>多家券商对 MOH 进行了评估。富国银行在 4 月 27 日（星期一）的研究报告中将 Molina Healthcare 的目标价从 141.00 美元上调至 159.00 美元，并给予该股票 “持平” 评级。瑞穗在周一的研究报告中设定了 Molina Healthcare 的目标价为 215.00 美元。美国银行在 4 月 29 日（星期三）将 Molina Healthcare 的评级从 “表现不佳” 上调至 “买入”，并设定了 250.00 美元的目标价。Cantor Fitzgerald 在 5 月 11 日（星期一）的研究报告中将 Molina Healthcare 的目标价从 144.00 美元上调至 209.00 美元，并给予该公司 “中性” 评级。最后，巴克莱在 5 月 26 日（星期二）的研究报告中将 Molina Healthcare 的目标价从 161.00 美元上调至 199.00 美元，并给予该公司 “减持” 评级。三位研究分析师对该股票给予 “买入” 评级，十一位给予 “持有” 评级，两位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “持有”，平均目标价为 182.73 美元。</p>
<p><strong>查看我们对 Molina Healthcare 的最新分析</strong></p>
<h2>内部人士下注</h2>
<ul>
<li>3 只在市场动荡中表现良好的健康保险股票</li>
</ul>
<p>在其他 Molina Healthcare 的新闻中，内部人士 Jeff D. Barlow 在 5 月 11 日（星期一）出售了 17,811 股该股票。股票以 186.12 美元的平均价格出售，总价值为 3,314,983.32 美元。出售完成后，该内部人士直接持有 67,175 股公司股票，价值为 12,502,611 美元。这代表其持股比例下降了 20.96%。该交易在提交给证券交易委员会的文件中披露，文件可在此链接查看。此外，首席会计官 Maurice Hebert 在 5 月 14 日（星期四）出售了 600 股公司的股票。该股票以 191.55 美元的平均价格出售，总交易额为 114,930.00 美元。交易完成后，首席会计官持有 12,815 股公司股票，价值约为 2,454,713.25 美元。该交易使其持股比例下降了 4.47%。该销售的 SEC 文件提供了更多信息。1.44% 的股票由公司内部人士持有。</p>
<h2>对 Molina Healthcare 的对冲基金看法</h2>
<p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。AQR 资本管理公司在第三季度将其在 Molina Healthcare 的股份增加了 217.0%。AQR 资本管理公司现在拥有 2,934,130 股公司股票，价值为 561,475,000 美元，此前在上个季度增持了 2,008,458 股。T. Rowe Price 投资管理公司在第四季度将其在 Molina Healthcare 的持股增加了 10.2%。T. Rowe Price 投资管理公司现在拥有 2,171,433 股公司股票，价值为 376,831,000 美元，此前增持了 201,772 股。在第四季度，Invesco Ltd.将其在 Molina Healthcare 的持仓增加了 24.2%。Invesco Ltd.现在拥有 1,690,981 股公司股票，价值为 293,453,000 美元，此前增持了 329,679 股。Victory Capital Management Inc.在第四季度将其在 Molina Healthcare 的股份增加了 46.4%。Victory Capital Management Inc.现在拥有 1,410,604 股公司股票，价值为 244,796,000 美元，此前增持了 447,078 股。最后，Dimensional Fund Advisors LP 在第四季度将其在 Molina Healthcare 的股份增加了 20.1%。Dimensional Fund Advisors LP 现在拥有 1,127,761 股公司股票，价值为 195,704,000 美元，此前增持了 189,084 股。98.50% 的股票由机构投资者持有。</p>
<h2>Molina Healthcare 公司简介</h2>
<p>（获取免费报告）</p>
<p>Molina Healthcare, Inc 是一家专注于政府资助健康保险项目的管理医疗公司。该公司提供医疗补助管理医疗计划、医疗保险优势计划和根据《平价医疗法案》提供的个人市场计划。通过综合护理模式，Molina 强调预防和初级护理服务、护理协调和疾病管理，以改善其成员的健康结果。</p>
<p>该公司的根源可以追溯到 1980 年代初，当时博士。</p>
<h2>另见</h2>
<ul>
<li>五只我们认为比 Molina Healthcare 更好的股票</li>
<li>随着股价下跌，分析师们正在提高他们对 Broadcom 的目标价</li>
<li>Everpure：人工智能存储的不确定性掩盖了快速增长</li>
<li>这只科技 ETF 正在超越 QQQ——而加拿大可能是原因之一</li>
<li>英特尔是市场上最被低估的人工智能对冲</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Molina Healthcare 吗？</h2>
<p>在考虑 Molina Healthcare 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Molina Healthcare 并不在名单上。</p>
<p>虽然 Molina Healthcare 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Molina医疗

<p>Molina Healthcare 更新了其 2026 财年的收益指引，将每股收益设定为 5.00 美元以上，低于市场共识预期的 5.18 美元。该公司最近报告了第一季度每股收益为 2.35 美元，超出预期。分析师们调整了目标价，美国银行将其评级上调至 “买入”，富国银行也提高了目标价。此外，内部人士 Jeff D. Barlow 和 Maurice Hebert 出售了股份，而像 AQR Capital Management 这样的机构投资者在最近几个季度显著增加了持股</p>

<p>Molina Healthcare (NYSE:MOH - Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 5.000- for the period, compared to the consensus EPS estimate of 5.180. The company issued revenue guidance of -.</p>
<div class="lb-trans"><p>Molina Healthcare（纽约证券交易所代码：MOH - 获取免费报告）在周四早上发布了 2026 财年的收益指引更新。该公司提供的每股收益指引为 5.000-，而市场共识的每股收益预期为 5.180。该公司发布的收入指引为-。</p>
</div><p>Get <strong>Molina Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Molina Healthcare</strong> 的提醒：</p>
</div><h2>Molina Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>Molina Healthcare 股票表现</h2>
</div><ul>
<li>3 Sectors to Buy While They're Down and 1 to Walk Away From</li>
</ul>
<div class="lb-trans"><ul>
<li>3 个下跌时值得购买的行业和 1 个应远离的行业</li>
</ul>
</div><p>MOH stock opened at $197.96 on Thursday. The firm has a 50 day moving average of $172.30 and a two-hundred day moving average of $163.88. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $311.52. The company has a market capitalization of $10.31 billion, a price-to-earnings ratio of 58.57 and a beta of 0.80. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.</p>
<div class="lb-trans"><p>周四，MOH 股票开盘价为 197.96 美元。该公司的 50 日移动平均线为 172.30 美元，200 日移动平均线为 163.88 美元。Molina Healthcare 的 12 个月低点为 121.06 美元，12 个月高点为 311.52 美元。该公司的市值为 103.1 亿美元，市盈率为 58.57，贝塔值为 0.80。该公司的速动比率为 1.63，流动比率为 1.63，债务股本比率为 0.97。</p>
</div><p>Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare's revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the firm earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities analysts anticipate that Molina Healthcare will post 5.23 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Molina Healthcare（纽约证券交易所代码：MOH - 获取免费报告）最近在 4 月 22 日（星期三）发布了季度财报。该公司报告季度每股收益为 2.35 美元，超出分析师共识预期的 1.57 美元，超出幅度为 0.78 美元。该季度的收入为 108 亿美元，而市场共识预期为 109.1 亿美元。Molina Healthcare 的净利润率为 0.42%，股本回报率为 8.76%。Molina Healthcare 的季度收入同比下降了 3.1%。去年同期，该公司每股收益为 6.08 美元。Molina Healthcare 已将其 2026 财年的指引设定为 5.000-每股收益。整体来看，股票分析师预计 Molina Healthcare 在当前财年将发布 5.23 美元的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>Centene 股票为何下跌 40%——现在是否值得购买</li>
</ul>
</div><p>A number of brokerages have weighed in on MOH. Wells Fargo &amp; Company boosted their price target on Molina Healthcare from $141.00 to $159.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Monday, April 27th. Mizuho set a $215.00 price objective on Molina Healthcare in a research note on Monday. Bank of America upgraded Molina Healthcare from an &#34;underperform&#34; rating to a &#34;buy&#34; rating and set a $250.00 target price for the company in a report on Wednesday, April 29th. Cantor Fitzgerald lifted their price target on shares of Molina Healthcare from $144.00 to $209.00 and gave the company a &#34;neutral&#34; rating in a research report on Monday, May 11th. Finally, Barclays raised their target price on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an &#34;underweight&#34; rating in a research note on Tuesday, May 26th. Three research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of &#34;Hold&#34; and an average target price of $182.73.</p>
<div class="lb-trans"><p>多家券商对 MOH 进行了评估。富国银行在 4 月 27 日（星期一）的研究报告中将 Molina Healthcare 的目标价从 141.00 美元上调至 159.00 美元，并给予该股票 “持平” 评级。瑞穗在周一的研究报告中设定了 Molina Healthcare 的目标价为 215.00 美元。美国银行在 4 月 29 日（星期三）将 Molina Healthcare 的评级从 “表现不佳” 上调至 “买入”，并设定了 250.00 美元的目标价。Cantor Fitzgerald 在 5 月 11 日（星期一）的研究报告中将 Molina Healthcare 的目标价从 144.00 美元上调至 209.00 美元，并给予该公司 “中性” 评级。最后，巴克莱在 5 月 26 日（星期二）的研究报告中将 Molina Healthcare 的目标价从 161.00 美元上调至 199.00 美元，并给予该公司 “减持” 评级。三位研究分析师对该股票给予 “买入” 评级，十一位给予 “持有” 评级，两位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “持有”，平均目标价为 182.73 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Molina Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Molina Healthcare 的最新分析</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><ul>
<li>3 Health Insurance Stocks Holding Green in Market Turmoil</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在市场动荡中表现良好的健康保险股票</li>
</ul>
</div><p>In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company's stock, valued at $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, CAO Maurice Hebert sold 600 shares of the business's stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Molina Healthcare 的新闻中，内部人士 Jeff D. Barlow 在 5 月 11 日（星期一）出售了 17,811 股该股票。股票以 186.12 美元的平均价格出售，总价值为 3,314,983.32 美元。出售完成后，该内部人士直接持有 67,175 股公司股票，价值为 12,502,611 美元。这代表其持股比例下降了 20.96%。该交易在提交给证券交易委员会的文件中披露，文件可在此链接查看。此外，首席会计官 Maurice Hebert 在 5 月 14 日（星期四）出售了 600 股公司的股票。该股票以 191.55 美元的平均价格出售，总交易额为 114,930.00 美元。交易完成后，首席会计官持有 12,815 股公司股票，价值约为 2,454,713.25 美元。该交易使其持股比例下降了 4.47%。该销售的 SEC 文件提供了更多信息。1.44% 的股票由公司内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Molina Healthcare</h2>
<div class="lb-trans"><h2>对 Molina Healthcare 的对冲基金看法</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC raised its stake in shares of Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company's stock valued at $561,475,000 after acquiring an additional 2,008,458 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Molina Healthcare by 10.2% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company's stock worth $376,831,000 after acquiring an additional 201,772 shares during the period. Invesco Ltd. raised its position in shares of Molina Healthcare by 24.2% during the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company's stock valued at $293,453,000 after acquiring an additional 329,679 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Molina Healthcare by 46.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company's stock valued at $244,796,000 after purchasing an additional 447,078 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of Molina Healthcare by 20.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,127,761 shares of the company's stock worth $195,704,000 after purchasing an additional 189,084 shares during the period. 98.50% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。AQR 资本管理公司在第三季度将其在 Molina Healthcare 的股份增加了 217.0%。AQR 资本管理公司现在拥有 2,934,130 股公司股票，价值为 561,475,000 美元，此前在上个季度增持了 2,008,458 股。T. Rowe Price 投资管理公司在第四季度将其在 Molina Healthcare 的持股增加了 10.2%。T. Rowe Price 投资管理公司现在拥有 2,171,433 股公司股票，价值为 376,831,000 美元，此前增持了 201,772 股。在第四季度，Invesco Ltd.将其在 Molina Healthcare 的持仓增加了 24.2%。Invesco Ltd.现在拥有 1,690,981 股公司股票，价值为 293,453,000 美元，此前增持了 329,679 股。Victory Capital Management Inc.在第四季度将其在 Molina Healthcare 的股份增加了 46.4%。Victory Capital Management Inc.现在拥有 1,410,604 股公司股票，价值为 244,796,000 美元，此前增持了 447,078 股。最后，Dimensional Fund Advisors LP 在第四季度将其在 Molina Healthcare 的股份增加了 20.1%。Dimensional Fund Advisors LP 现在拥有 1,127,761 股公司股票，价值为 195,704,000 美元，此前增持了 189,084 股。98.50% 的股票由机构投资者持有。</p>
</div><h2>Molina Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Molina Healthcare 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.</p>
<div class="lb-trans"><p>Molina Healthcare, Inc 是一家专注于政府资助健康保险项目的管理医疗公司。该公司提供医疗补助管理医疗计划、医疗保险优势计划和根据《平价医疗法案》提供的个人市场计划。通过综合护理模式，Molina 强调预防和初级护理服务、护理协调和疾病管理，以改善其成员的健康结果。</p>
</div><p>The company traces its roots to the early 1980s, when Dr.</p>
<div class="lb-trans"><p>该公司的根源可以追溯到 1980 年代初，当时博士。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Molina Healthcare</li>
<li>As Shares Fall, Analyst Are Boosting their Broadcom Price Targets</li>
<li>Everpure: AI Storage Uncertainty Overshadows Breakneck Growth</li>
<li>This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason</li>
<li>Intel Is the Market's Most Mispriced AI Hedge</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Molina Healthcare 更好的股票</li>
<li>随着股价下跌，分析师们正在提高他们对 Broadcom 的目标价</li>
<li>Everpure：人工智能存储的不确定性掩盖了快速增长</li>
<li>这只科技 ETF 正在超越 QQQ——而加拿大可能是原因之一</li>
<li>英特尔是市场上最被低估的人工智能对冲</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NYSE&amp;Symbol=MOH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Molina Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Molina Healthcare 吗？</h2>
</div><p>Before you consider Molina Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Molina Healthcare 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Molina Healthcare 并不在名单上。</p>
</div><p>While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Molina Healthcare 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Molina 医疗（NYSE:MOH）更新了 2026 财年的收益指引